CD274 and liver cancer: Among 240 patients suffering primary liver cancer, the prognosis and overall survival rate of patients with high PD-L1 expression are significantly less than those with low or negative PD-L1 expression, and the researchers purposed that the expression level of PD-L1 in patients with liver cancer maybe an independent factor to predict postoperative liver cancer recurrence (16).